News Sharing
For sharing news, please enter the email address of you and the receiver, then press SEND button.*Mandatory Fields
Receiver*
Enter email addresses, separated by semicolon (;). E.g. a@a.com;b@b.com
Your email address*
Content Sharing
Meta (META.US) Launches Two Ray-Ban AI Prescription Glasses Priced from USD499
Meta (META.US) announced on Tuesday the launch of two Ray-Ban smart prescription glasses, expanding its product range in this field.The new glasses are now available for pre-order ...
Reset
Send
The window will close in 5 seconds
Meta (META.US) Launches Two Ray-Ban AI Prescription Glasses Priced from USD499
Close
Recommend
2
Positive
2
Negative
0
 
 

Meta (META.US)      announced on Tuesday the launch of two Ray-Ban smart prescription glasses, expanding its product range in this field.

The new glasses are now available for pre-order in the US, starting at USD499. The company stated that the new products, Ray-Ban Meta Blayzer Optics and Ray-Ban Meta Scriber Optics, will be available from April 14 at eyewear retailers in the US and select international markets.

Related NewsContinuing Jobless Claims for Mar/21 in the United States is 1,841K, higher than the previous value of 1,816K. The forecast was 1,840K.
(sw/t)(Real-time Streaming US Stocks Quote; Except All OTC quotes are at least 15 minutes delayed.)



This article was automatically translated by AI, the Chinese version should be considered the authoritative version. AASTOCKS.com Limited does not guarantee its accuracy or completeness and accepts no liability for any damages or losses arising from the use of this translation.

Auto-translated by AI

AASTOCKS Financial News

Copyright(C) AASTOCKS.com Limited 2000. All rights reserved.
Disclaimer: AASTOCKS.com Ltd, HKEx Information Services Limited, its holding companies and/or any subsidiaries of such holding companies endeavour to ensure the accuracy and reliability of the Information provided but do not guarantee its accuracy or reliability and accept no liability (whether in tort or contract or otherwise) for any loss or damage arising from any inaccuracies or omissions.